David J. Caponera
Corporate Officer/Principal bij DICERNA PHARMACEUTICALS, INC.
Profiel
David J.
Caponera is currently the Head of Patient Advocacy and Patient Services at Dicerna Pharmaceuticals, Inc. Previously, he worked as the VP of Patient Engagement and Access Support at Catalyst Pharmaceuticals, Inc. from 2014 to 2018.
He received his graduate degree from Duke University and his undergraduate degree from Cornell University.
Actieve functies van David J. Caponera
| Bedrijven | Functie | Begin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13-06-2019 |
Eerdere bekende functies van David J. Caponera
| Bedrijven | Functie | Einde |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2018 |
Opleiding van David J. Caponera
| Duke University | Graduate Degree |
| Cornell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
